4周维护ICS-Formoterol与ICS在成年人中新诊断的轻度喘:对症状,肺功能和炎症的影响
Yan Zhou1, Xue Zhang1, Zichong Xu1
1Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 100, Haining Road, Hongkou District, Shanghai, 200080, China.
Current allergy and asthma reports
|September 23, 2025
概括
在一项为期4周的研究中,与单独的ICS相比,使用吸入性皮质类固醇 (ICS) 加上formoterol开始轻度喘治疗显著改善了喘控制和肺功能.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床试验 临床试验
背景情况:
- 轻度喘管理指导方针正在发展,而"轻度喘"是一个回顾性标签.
- 目前对轻度喘初始短期维持策略的研究是有限的.
- 早期客观评估对于指导轻度喘治疗决策至关重要.
研究的目的:
- 在新诊断的轻度喘中,与吸入性皮质类固醇 (ICS) 加上formoterol和单独使用ICS进行为期4周的维持治疗的疗效进行比较.
- 评估这些初始策略对喘控制,肺功能和呼吸道炎症的影响.
主要方法:
- 两项前性研究的回顾性分析,涉及128名新诊断的轻度喘患者.
- 喘控制指标的比较 (喘控制测试,喘控制问卷),肺功能 (FEV1,FEV1/FVC) 和呼吸道炎症 (乙氨基小细胞减少).
主要成果:
- 无论是ICS-formoterol还是单独的ICS都改善了喘控制,肺功能和呼吸道炎症.
- ICS-formoterol组在喘控制得分,大和小气道功能以及异氨基小细胞减少方面表现出显著更大的改善.
- 在基线小气道功能障碍患者中,改善尤为显著.
结论:
- 用ICS-formoterol进行为期四周的维持治疗是对轻度喘的有效初始策略.
- 与单独的ICS相比,这种方法在喘控制和肺功能方面提供了更好的好处.
- 建议对治疗进行重新评估,以指导长期管理策略.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
COPD: Management Using Bronchodilators and Corticosteroids
692
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
692
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K


